chartexchange

Nurix Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire Inc. | Nov 10, 2026 7:00 AM EST

BRISBANE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that Company management will participate in fireside chats at the following investor conferences:

Read original article